TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers mapped immune aging using blood-cell data from 2,609 adults and applied a protein-based model to 50,000 UK Biobank participants. A granzyme B-dominant pattern in people who were initially healthy was associated with greater risk of several chronic conditions and death over the following decade; it is not a diagnosis or proof of cause.
Researchers from Washington University School of Medicine in St. Louis, Nationwide Children’s Hospital and King’s College London have mapped differences in how adults’ immune systems age, reporting that a blood-protein pattern associated with granzyme B-producing immune cells was linked to greater risk of future chronic disease and death. The study, published Oct. 9 in Immunity, points to a possible way to identify immune-aging patterns before a clinical diagnosis, but does not establish that the cell pattern causes disease.
The team analyzed about 12.4 million immune cells from blood samples of 2,609 mainly healthy adults aged 20 to over 90, drawn from eight cohorts in North America, the United Kingdom, Asia and Australia. Younger participants tended to have more naive immune cells, which have not yet encountered specific pathogens. Older participants showed more varied profiles, including differences in cells associated with inflammation.
To describe those differences, the researchers compared two types of effector memory CD8 T cells: cells producing granzyme B, which can directly destroy diseased cells, and cells producing granzyme K, which may help signal or coordinate immune responses. The team then developed a computer model using a smaller dataset with cell counts and blood-protein measurements to estimate where people fell on this spectrum from protein patterns.
Researchers applied that model to baseline protein samples from 50,000 UK Biobank participants who were initially healthy. Their health records were followed for up to 15 years. People whose estimated profile leaned toward granzyme B cells had higher subsequent risks of death and were more likely to develop conditions including type 2 diabetes, hypertension, liver disease and renal failure than those with more granzyme K cells. The report does not give a single risk estimate for those outcomes in the supplied material.
A Potential Signal Before Diagnosis
The findings suggest that chronological age alone may not capture differences in immune health. If further research confirms the association, a blood-based measure of immune aging could help identify people whose immune systems show signs of stress before symptoms or a formal diagnosis appear. That could give clinicians another signal to consider when deciding whether further assessment is appropriate.
For now, the map is a research finding, not a screening test with demonstrated clinical benefit. Researchers said applying it currently requires specialized, costly technology. The team is adapting the work toward a blood test that could use standard equipment, but the source report does not establish that such a test is available or ready for routine care.
As an affiliate, we earn on qualifying purchases.
How Researchers Built the Map
The study addresses why people of the same age can experience different patterns of health as they grow older. The researchers placed participants along a spectrum based on the balance between granzyme B- and granzyme K-producing CD8 T cells. Their results indicate that profiles may differ well before old age: some people can show a granzyme B-dominant pattern earlier in life.
Because the UK Biobank records did not include the relevant CD8 T-cell counts for the large group of participants, the researchers first trained a model on a smaller dataset that did. They used blood proteins to estimate the immune-cell balance in the larger cohort, then compared those estimates with up to 15 years of recorded medical events. This design allowed the team to examine later health outcomes, while relying on a model rather than direct cell counts for the 50,000-person analysis.
“There are clues in the blood that can tell us whether someone is on a healthy or unhealthy aging trajectory.”
— Maxim N. Artyomov, co-corresponding author and professor at Washington University School of Medicine
As an affiliate, we earn on qualifying purchases.
Limits of the Risk Estimate
The reported results show an association between an estimated immune-cell profile and later health outcomes; they do not show that granzyme B-producing cells cause chronic disease or death. The supplied report also does not state the size of the increased risks, how well the model predicts outcomes for an individual, or whether the associations hold equally across all populations and conditions.
The large-cohort analysis inferred cell patterns from blood proteins because UK Biobank did not contain the needed CD8 T-cell counts. Further work would need to clarify how accurately that estimate reflects each person’s immune system and whether using the measure to guide care improves health outcomes. It is also unclear when, or whether, the proposed standard-equipment blood test will be available.
blood protein test for chronic disease risk
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Research Map to Blood Test
Artyomov and his lab are working to adapt the research into a simpler blood test that can be processed with standard equipment, according to the report. The proposed goal is to flag possible subclinical immune stress so physicians can decide whether specialized testing is warranted. No release date, clinical validation results or plan for routine use was provided.
Until those details are available, the findings remain a research tool for studying immune aging and future risk. Further validation will be needed before clinicians or patients can know how reliably the map predicts outcomes or whether it should affect preventive-care decisions.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the immune-aging study find?
The researchers reported that, among initially healthy adults in a UK Biobank analysis, a modeled immune profile leaning toward granzyme B-producing cells was associated with higher later risks of death and several chronic conditions.
Does a granzyme B-dominant profile mean someone has a disease?
No. The study authors describe the pattern as a possible sign that the body may be off track, not a formal diagnosis. The findings do not establish that an individual with this profile will develop a particular condition.
How many people were included?
Researchers analyzed about 12.4 million immune cells from 2,609 adults to map immune aging. They then used a protein-based model to estimate immune profiles in 50,000 UK Biobank participants.
Can people get this blood test now?
The report does not say that a clinical test is available. The team is adapting its research toward a simpler test, but its readiness, accuracy and availability have not been established in the supplied material.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
